Aurinia Pharmaceuticals Inc.
AUPH
$12.27
$0.191.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 220.43% | 163.69% | 107.37% | 70.78% | 30.78% |
| Total Depreciation and Amortization | -2.14% | 23.31% | 66.95% | 182.38% | 707.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.79% | -51.23% | -62.65% | 14.70% | 10.55% |
| Change in Net Operating Assets | -8,989.69% | -201.99% | 185.66% | -74.66% | -102.03% |
| Cash from Operations | 5,488.60% | 415.30% | 232.66% | 176.59% | 95.64% |
| Capital Expenditure | -18.56% | -11.23% | 41.36% | 20.61% | 52.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 411.77% | 19.04% | 762.71% | -98.32% | 54.90% |
| Cash from Investing | 402.40% | 19.21% | 685.48% | -79.35% | 54.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 23.94% | 6.41% | -19.59% | -345.20% | -- |
| Issuance of Common Stock | 70.49% | 69.63% | 109.02% | 123.48% | 223.97% |
| Repurchase of Common Stock | -378.30% | -349.07% | -2,186.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -282.60% | -282.12% | -856.96% | -2,886.17% | -1,000.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.57% | 108.02% | 176.29% | 76.66% | 30.93% |